Pavan Cheruvu
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Pavan K.
Cheruvu is currently Chief Executive Officer & Director at Amanat Acquisition Corp.
Former positions include Chief Executive Officer at Sio Gene Therapies, Inc. from 2018 to 2018, Chief Executive Officer at Axovant Sciences, Inc. from 2018 to 2020, and President, Chief Executive Officer & Director at Bitterroot Bio, Inc. Education includes undergraduate studies at Duke University, graduate studies at the University of Oxford, and a doctorate from Harvard Medical School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
6,9% | 19/05/2026 | 150 000 ( 6,9% ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Directeur Général | 01/02/2026 |
| SIO GENE THERAPIES INC. | Directeur Général | 31/01/2022 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur Général | 01/12/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national